Union Springs Pharmaceuticals Announces Agreement to Commercialize Products Using a Revolutionary Antimicrobial Technology

ERLANGER, Ky.--(BUSINESS WIRE)--Kentucky-based Union Springs Pharmaceuticals announced today an agreement with BIOSAFE® of Pittsburgh to market products containing the patented and novel antimicrobial polymer, HM4100. Similar to its flagship product, MyClyns® (antimicrobial germ spray), Union Springs Pharmaceuticals will identify the products as MyClyns Antimicrobial Surface Treatments and will be the first company to bring these unique products to the market.
MORE ON THIS TOPIC